Humaid Al-Shamsi: Nexomic Brings the Largest Team Representation to ESMO AI 2026
Humaid Al-Shamsi/LinkedIn

Humaid Al-Shamsi: Nexomic Brings the Largest Team Representation to ESMO AI 2026

Humaid Al-Shamsi, The Chairman of Nexomic, CEO of Burjeel Cancer Institute (BCI) Comprehensive Cancer Center, shared on LinkedIn:

“With Nexomic team ESMO AI 2026.

Proud of our team and the amazing milestones we have achieved in no time.

The largest representation from a single institution or biotech company globally.”

About ESMO AI 2026

The ESMO AI and Digital Oncology Congress 2026, taking place November 16–18 in Berlin, Germany, brings together oncology professionals, researchers, AI experts and digital health specialists to explore how artificial intelligence and digital technologies are shaping cancer research and clinical practice.

The congress focuses on scientific advances, clinical applications, methodology, ethics, regulation and the integration of AI-driven innovations into real-world oncology care, highlighting the evolving role of technology in advancing cancer diagnosis, treatment and precision medicine.

You can also read: Humaid Al-Shamsi: Nexomic Leads ESMO AI in Berlin with 10 Scientific Contributions